Investigating chemotherapy-resistant ovarian cancer

Dr Marion Butler

Ovarian cancer causes around 266 women to lose their lives from this disease each year in Ireland. Patients are treated with a given chemotherapy and although most respond initially, when patients fail to respond upon cancer recurrence there is no good drug alternative.

Dr Marion Butler found that ovarian cancer cells that don’t die when treated with this drug grow slower when we block a given protein from working. In this project the team plan to test whether blocking this protein reduces tumour growth using these chemotherapy-resistant ovarian cancer cells in animal studies.

Findings from this project will inform us on whether we should explore the targeting of this protein when drug resistance develops.

 

Back
Start year
2020
End Year
2021
Principal Investigator
Dr. Marion Butler
Researcher
Jamie Casey
Institution
Maynooth University
Grant funding
IRC New Foundations Grant in partnership with Breakthrough Cancer Research
Linked Breakthrough Research Priorities
1, 3, 4